Literature DB >> 17884234

Sprinting without myostatin: a genetic determinant of athletic prowess.

Se-Jin Lee1.   

Abstract

Genetic studies in several species have demonstrated that myostatin (MSTN) normally functions to limit skeletal muscle mass. In a recent study, Mosher et al. reported that a mutation in the canine MSTN gene is responsible for the double-muscling phenotype seen in 'bully' whippets. Furthermore, they show that loss of even one functional MSTN allele seems to confer a competitive advantage to racing whippets, providing the first definitive evidence that loss of myostatin function can enhance athletic performance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17884234     DOI: 10.1016/j.tig.2007.08.008

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  27 in total

1.  METABOLIC FUNCTIONS OF MYOSTATIN AND GDF11.

Authors:  Alexandra C McPherron
Journal:  Immunol Endocr Metab Agents Med Chem       Date:  2010-12

2.  Follistatin treatment suppresses SERCA1b levels independently of other players of calcium homeostasis in C2C12 myotubes.

Authors:  János Fodor; Adrienn Gomba-Tóth; Tamás Oláh; János Almássy; Ernő Zádor; László Csernoch
Journal:  J Muscle Res Cell Motil       Date:  2017-06-21       Impact factor: 2.698

Review 3.  Approaching a new age in Duchenne muscular dystrophy treatment.

Authors:  Kathryn R Wagner
Journal:  Neurotherapeutics       Date:  2008-10       Impact factor: 7.620

Review 4.  Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.

Authors:  Harrison G Pope; Ruth I Wood; Alan Rogol; Fred Nyberg; Larry Bowers; Shalender Bhasin
Journal:  Endocr Rev       Date:  2013-12-17       Impact factor: 19.871

5.  The effects of endoplasmic reticulum stress response on duck decorin stimulate myotube hypertrophy in myoblasts.

Authors:  Lingli Sun; Kai Lu; Hehe Liu; Haohan Wang; Xinxin Li; Chao Yang; Liang Li; Jiwen Wang
Journal:  Mol Cell Biochem       Date:  2013-02-06       Impact factor: 3.396

6.  Cytotoxic aggregation and amyloid formation by the myostatin precursor protein.

Authors:  Carlene S Starck; Andrew J Sutherland-Smith
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

7.  Systemic myostatin inhibition via liver-targeted gene transfer in normal and dystrophic mice.

Authors:  Kevin J Morine; Lawrence T Bish; Klara Pendrak; Meg M Sleeper; Elisabeth R Barton; H Lee Sweeney
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

8.  Myostatin is upregulated following stress in an Erk-dependent manner and negatively regulates cardiomyocyte growth in culture and in a mouse model.

Authors:  Lawrence T Bish; Kevin J Morine; Meg M Sleeper; H Lee Sweeney
Journal:  PLoS One       Date:  2010-04-19       Impact factor: 3.240

9.  Redundancy of myostatin and growth/differentiation factor 11 function.

Authors:  Alexandra C McPherron; Thanh V Huynh; Se-Jin Lee
Journal:  BMC Dev Biol       Date:  2009-03-19       Impact factor: 1.978

10.  Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity.

Authors:  Tingqing Guo; William Jou; Tatyana Chanturiya; Jennifer Portas; Oksana Gavrilova; Alexandra C McPherron
Journal:  PLoS One       Date:  2009-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.